Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $11,276.20 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 20 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $563.81, for a total transaction of $11,276.20. Following the completion of the sale, the senior vice president now directly owns 1,983 shares in the company, valued at approximately $1,118,035.23. This trade represents a 1.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mark Brosius also recently made the following trade(s):

• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.00, for a total transaction of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total value of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The shares were sold at an average price of $533.18, for a total value of $260,725.02.
• On Wednesday, March 5th, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $554.17, for a total value of $272,651.64.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The shares were sold at an average price of $573.78, for a total value of $282,299.76.

Intuitive Surgical Stock Performance

ISRG stock opened at $563.60 on Monday. The company has a market capitalization of $202.00 billion, a PE ratio of 87.93, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a one year low of $395.60 and a one year high of $616.00. The company’s 50 day moving average price is $505.22 and its two-hundred day moving average price is $536.84.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the company earned $1.50 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Woodline Partners LP boosted its holdings in Intuitive Surgical by 35.3% during the 1st quarter. Woodline Partners LP now owns 112,172 shares of the medical equipment provider’s stock valued at $55,555,000 after acquiring an additional 29,283 shares during the period. MBB Public Markets I LLC purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $318,000. Ascent Group LLC lifted its position in Intuitive Surgical by 4.9% in the first quarter. Ascent Group LLC now owns 6,102 shares of the medical equipment provider’s stock valued at $3,022,000 after purchasing an additional 284 shares during the last quarter. United Services Automobile Association purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $4,039,000. Finally, Arete Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 14.8% during the first quarter. Arete Wealth Advisors LLC now owns 2,191 shares of the medical equipment provider’s stock valued at $1,086,000 after purchasing an additional 283 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on ISRG. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Piper Sandler decreased their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.